Biological targeting and activity of pre-fibrillar Aβ assemblies

Kyle C. Wilcox, Jason Pitt, Adriano Sebollela, Helen Martirosova, Pascale N. Lacor, William L. Klein*

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Scopus citations

Abstract

The body of work from the past decade has advanced our understanding of how toxic oligomers of Aβ are capable of eliciting the spectrum of pathological and behavioral hallmarks of Alzheimer's disease. These potent neurotoxins now provide a molecular basis for the cause of this disease as well as a basis for identifying and evaluating diagnostic and therapeutic strategies. Oligomer toxicity is mediated by a number of factors-both in the targeting of these toxins to the neuronal synapses and in the transduction of this targeting into intracellular signals resulting in synapse loss and, eventually, cell death. Recent investigations have focused on defining the mechanisms of binding of toxic Aβ oligomers, the pathways modulated by these events, and strategies to treat Alzheimer's disease by targeting both aspects. One promising facet of recent research highlighted in this chapter, and in which Aβ oligomers play a central role, is the unfolding of connection between Alzheimer's disease and insulin signaling in the aging brain.

Original languageEnglish (US)
Title of host publicationNon-fibrillar Amyloidogenic Protein Assemblies - Common Cytotoxins Underlying Degenerative Diseases
PublisherSpringer Netherlands
Pages103-133
Number of pages31
Volume9789400727748
ISBN (Electronic)9789400727748
ISBN (Print)9400727739, 9789400727731
DOIs
StatePublished - Mar 1 2012

Keywords

  • Alzheimer's disease
  • Alzheimer's therapeutics
  • Aβ oligomers
  • Insulin signaling

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Biological targeting and activity of pre-fibrillar Aβ assemblies'. Together they form a unique fingerprint.

Cite this